Report Descriptions:

The Global Endoscopic Hemostasis Devices Market was estimated at USD 2.18 billion in 2026 and is projected to reach USD 3.32 billion by 2035, reflecting a robust CAGR of 4.32% over the forecast period from 2026 to 2035. The Endoscopic Hemostasis Devices market report offers a comprehensive and nuanced view of the industry, moving beyond conventional analysis. It provides a thorough examination of the markets dynamics, encompassing a detailed exploration of the factors propelling growth, such as evolving economic conditions, advancements in technology, shifts in regulatory policies, and changes in consumer behavior. Furthermore, the report discusses the projected Compound Annual Growth Rate (CAGR), providing stakeholders with a clear understanding of the market's expected growth trajectory and offering data-driven insights into future market dynamics.

The Endoscopic Hemostasis Devices market under analysis is characterized by dynamic growth and evolving trends that are reshaping the competitive landscape. With 2025 serving as the base year for this Endoscopic Hemostasis Devices market study, recent data highlights a significant expansion driven by technological advancements, rising consumer demand, and a growing focus on innovation. Companies are refining their go-to-market (GTM) strategies to effectively capture these emerging opportunities and respond to the rapidly changing market dynamics.

Key trends influencing the Endoscopic Hemostasis Devices market include the rapid adoption of digital technologies, the integration of sustainable practices, and the increasing importance of customer experience. These trends are not only driving growth but also creating new challenges for industry participants, who must adapt their GTM strategies to navigate regulatory changes, supply chain disruptions, and fluctuating economic conditions. Despite these challenges, the Endoscopic Hemostasis Devices market is poised for sustained growth, with emerging markets playing a critical role in the expansion of the industry.

Looking ahead, the Endoscopic Hemostasis Devices market is forecasted to continue its upward momentum through 2035, supported by ongoing investments in research and development, strategic partnerships, and mergers and acquisitions. Companies that can effectively tailor their GTM strategies to the evolving market landscape, innovate, and meet shifting consumer demands are likely to achieve sustained success. Endoscopic Hemostasis Devices market report provides a comprehensive analysis of the current market environment and offers valuable insights into the key drivers, challenges, and opportunities that will shape the industry's future over the next decade. This report offers a comprehensive analysis of market dynamics across various segments, regions, and countries, incorporating both qualitative and quantitative data. It covers the period from 2017 to 2035, providing a detailed examination of historical performance, current market conditions, and future projections.

Historical Analysis (2017-2024): The report presents a thorough review of market trends, performance metrics, and growth trajectories for the years 2017 through 2024. This historical perspective is crucial for understanding past market behavior and identifying patterns that influence current and future market dynamics.

Forecast and Projections (2026-2035) : Building on historical data, the report provides forward-looking insights, including market forecasts and growth projections from 2026 to 2035. It details anticipated market trends, emerging opportunities, and potential challenges across different segments, regions, and countries.

Compound Annual Growth Rate (CAGR): The report includes a precise calculation of the compound annual growth rate (CAGR) for the forecast period of 2026 to 2035. This metric will be instrumental in assessing the expected growth trajectory and the overall market potential during the forecast period.

Endoscopic Hemostasis Devices Market

Endoscopic Hemostasis Devices Market

The Endoscopic Hemostasis Devices Market includes medical tools used to stop internal bleeding during endoscopic procedures. These devices are inserted through flexible endoscopes and are used to treat bleeding in the gastrointestinal (GI) tract, such as ulcers, varices, or bleeding after surgery or biopsy.

These tools are used in hospitals, surgical centres, and emergency departments. Common types include thermal probes, mechanical clips, injection needles, sprays, and topical agents. They allow doctors to stop bleeding without open surgery, reducing recovery time and hospital stays. The market continues to grow due to rising demand for minimally invasive care and better treatment of GI bleeding.

What are the drivers of endoscopic hemostasis devices market

The increasing number of patients with gastrointestinal bleeding caused by ulcers, polyps, tumours, and other GI conditions. According to survey of Rome foundation, 36.6% of males and 49% of females were diagnosed for at least one Functional Gastrointestinal Disorder. These cases often need quick and effective control of bleeding, and endoscopic tools help doctors do this without major surgery.

Hospitals and surgical centres are choosing endoscopic procedures more often because they are safer and allow patients to recover faster. Hemostasis tools used during these procedures are critical for preventing further complications.

Aging populations around the world are also increasing the demand for GI care. Older adults are more likely to suffer from bleeding in the stomach or intestines, especially if they take blood thinners. This leads to more procedures where endoscopic bleeding control is needed.

Technology improvements have led to the creation of better and easier-to-use hemostatic tools. Newer clips, sprays, and thermal probes offer faster bleeding control and fewer side effects, which makes them more widely used in hospitals.

More training programs and guidelines are now available for endoscopic bleeding control. This helps ensure that doctors use these tools correctly, improving outcomes and building confidence in these procedures.

What are the challenges and restraining factors of endoscopic hemostasis devices market

The challenge in market is high cost of advanced hemostasis devices. Some tools are single-use and expensive, making it hard for smaller clinics or low-income hospitals to afford them regularly.

There are also concerns about device handling. Some clips or probes can be hard to position, especially in patients with active bleeding or difficult anatomy. This can make procedures longer and increase the risk of complications.

In some countries, the availability of trained staff is limited. Not all hospitals have endoscopists skilled in advanced bleeding control techniques. This affects the adoption of new devices in certain regions.

Regulatory approval and reimbursement are other hurdles. Some newer devices take time to receive approval from national health authorities. In many markets, insurance may not fully cover the cost of these tools, which slows down their use.

Some agents have limited shelf life and there is need for strict storage conditions. This creates added cost and logistical concerns for hospitals and suppliers.

What are the regional trends of endoscopic hemostasis devices market

North America holds the largest market share due to high rates of gastrointestinal disorders, early detection programs, and strong hospital infrastructure. In the United States, routine colonoscopy screening for colorectal cancer often leads to the identification and treatment of bleeding polyps or ulcers. The availability of skilled endoscopists and reimbursement for GI procedures supports high adoption of hemostasis tools. For example, U.S. hospitals regularly use rotatable endoscopic clips and thermal coagulation probes during routine colonoscopies and emergency bleeding control.

Europe shows steady growth supported by public healthcare coverage and strong clinical training programs. Countries like Germany and France have long-standing endoscopy units in major hospitals. The availability of locally manufactured clips and sprays helps reduce device cost and ensures regular supply. In Europe, guidelines recommend the use of injectable agents and clips for upper GI bleeds caused by ulcers, promoting widespread use of these tools in NHS hospitals.

Asia Pacific is the fastest-growing region due to rising awareness, aging populations, and increased investment in hospital infrastructure. Japan leads in device innovation and adoption, with hospitals using advanced soft-tipped clips and hemostatic powders for bleeding control in elderly patients with gastric ulcers. In South Korea, rising rates of endoscopic submucosal dissection (ESD) procedures increase demand for hemostatic sprays and coagulation tools. China is also rapidly adopting such devices through its public hospital expansion programs.

Growth in Latin America is moderate but improving, driven by urban hospital upgrades and rising GI case numbers. In Brazil and Mexico, tertiary hospitals are using mechanical clips and bipolar devices for bleeding caused by varices or cancer biopsies. Private hospitals in these countries are more likely to adopt newer tools, while public hospitals often rely on basic injection-based hemostasis due to cost concerns.

UAE and Saudi Arabia are equipping specialty hospitals with modern endoscopy units that use hemostasis clips and topical powders. South Africa is seeing increased use of thermal devices and sprays in government-funded teaching hospitals. However, device availability and trained staff remain limited in rural or low-resource areas.

Country-Wise Outlook:

United States drives market growth with advanced care and strong device adoption: The U.S. leads the market due to high rates of GI disorders, early detection, and widespread use of endoscopy. Most large hospitals have teams skilled in using hemostasis clips, sprays, and probes.

Insurance coverage in the U.S. often supports endoscopic treatment, which helps increase demand. U.S. manufacturers also play a major role in supplying tools worldwide. Regular training workshops and national treatment guidelines help ensure safe and effective device use.

Germany supports endoscopic care through public funding and technical leadership: Germany has a strong public healthcare system that covers endoscopic bleeding control. Hospitals have access to a wide range of modern hemostasis tools, and local companies contribute to device innovation and supply.

Training and standard protocols are part of Germanys national care system. This ensures skilled use of advanced clips, sprays, and thermal probes during GI procedures. Germany is also involved in clinical trials and research in this field.

Japan focuses on precision tools and elderly GI care: Japan faces high rates of GI bleeding, especially in older patients. The country is known for producing high-quality endoscopy tools, including specialized hemostasis devices.

Hospitals use these tools for both planned and emergency procedures. Japan also leads in developing soft-tipped clips, quick-release needles, and safe sprays. Its public health system supports early screening and treatment, boosting demand for such tools.

Competitive Analysis:

The endoscopic hemostasis devices market includes a mix of large international companies and smaller regional firms. Larger companies usually offer a full set of tools, such as clips to stop bleeding, probes that use heat to seal blood vessels, and needles to inject medicine into bleeding areas. These products are used in hospitals and clinics that perform a high number of endoscopy procedures.

Smaller companies often focus on just one or two types of devices. Some create low-cost clips or simple spray systems that are more affordable for hospitals in countries with limited budgets. Others focus on training programs or service support to help doctors learn how to use the tools correctly, especially in areas where skilled staff is limited.

Companies that continue to improve their products tend to perform better in this market. Doctors prefer tools that are safe, easy to use, and work quickly to stop bleeding. Devices that make procedures shorter and simpler are also more likely to be chosen by hospitals.

Firms that build strong relationships with hospitals, training centers, and medical suppliers are usually more successful. Hospitals are more likely to choose products from companies that offer good training, reliable supply, and support. Also, if a device has been approved by national health authorities, is easy to order, and has been shown to work well in real-life cases, it is more likely to be used regularly by doctors.

Key players in the market are Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Cook Medical, Medtronic plc, ERBE Elektromedizin GmbH, Johnson & Johnson (Ethicon Endo-Surgery), Pentax Medical (HOYA Corporation), STERIS plc, Fujifilm Holdings Corporation, Taewoong Medical Co. Ltd., B. Braun Melsungen AG, Karl Storz SE & Co. KG, Medi-Globe GmbH, Cantel Medical Corporation, and other players.

Recent Development:

In March 2023, Olympus Europa SE & Co. KG (Olympus), a global leader in the MedTech space, announced that Odin Medical Ltd. (Odin Vision), a group company of Olympus, has received CE-mark approval as a medical device company in Europe with its innovative cloud-AI (artificial intelligence) endoscopy medical devices: CADDIE, CADU, and SMARTIBD under the Medical Device Regulation (MDR).

In March 2025, Integrated Endoscopy, a pioneer in wireless arthroscopy solutions, and Intelliscopes, a leader in AI (artificial intelligence) enhanced endoscopy, announced a strategic partnership to improve surgical efficiencies and patient outcomes. The partnership seeks to revolutionize the surgical landscape by integrating Integrated Endoscopy's state-of-the-art wireless arthroscopy platform with Intelliscopes' industry-first, AI-based technology.

Study Period for the Endoscopic Hemostasis Devices Market:

Endoscopic Hemostasis Devices Market

Report Highlights:

Our team of experienced researchers has meticulously gathered and analyzed data to deliver a thorough examination of market dynamics, competitive landscape, and emerging technologies. With a focus on delivering actionable intelligence, this report aims to empower decision-makers with the information needed to make informed choices and stay ahead of the competition. Whether you are a seasoned industry player or a new entrant, our market research report serves as a strategic tool to navigate the complexities of the market, aiding in successful business planning and growth strategies.

Key Chapters of our Endoscopic Hemostasis Devices Market Report includes:

Market Dynamics, Variables, and Industry Analysis:

This chapter of our Endoscopic Hemostasis Devices market report provides an in-depth examination of the factors shaping the industry landscape. This section typically encompasses several key elements to offer a comprehensive understanding of the industry landscape such as market drivers & restraints analysis, market opportunities & trend analysis, market size & growth analysis, competitive analysis, SWOT analysis, business environment tools such as Porter's five forces & PESTEL analysis, Ansoff Matrix analysis, penetration & growth prospect analysis, regulatory framework & reimbursement scenario analysis, impact of macro & micro economic factors analysis such as Covid-19 impact, GDP growth, market inflation, U.S.- China trade war, Russia-Ukraine war impact, and supply chain analysis.

Segment Analysis & Forecast to 2035:

The segment analysis chapter of Endoscopic Hemostasis Devices market report is a critical section that delves into a detailed examination of the market's various segments. Segmentation involves dividing the market into distinct categories based on certain criteria to better understand and address the diverse needs of consumers. This chapter typically follows the introduction and provides a more granular view of the market, offering valuable insights for businesses and stakeholders. The components of the chapter lude segment definitions to understand the inclusions and exclusions of the study, assumptions, market size estimates and growth trend analysis of each segment, qualitative analysis of the segment, technological advancements, market penetration rate, market adoption rate, market share examination by each segment, segment growth drivers and restraint barriers, consumer behaviour and challenge analysis.

Regional Market Analysis & Forecast to 2035:

The chapter in Endoscopic Hemostasis Devices market research report is a pivotal section that examines and predicts the market dynamics and trends specific to different geographical regions. This chapter is crucial for businesses and stakeholders seeking a comprehensive understanding of how the market behaves across various locations, enabling them to tailor strategies and make informed decisions based on regional variations. The regional analysis chapter of our Endoscopic Hemostasis Devices market report is classified into regions & country-level. The chapter consists of North America (U.S., Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Sweden, Denmark, Norway, Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, Thailand, Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, Colombia, Rest of Latin America), Middle East & Africa (South Africa, Saudi Arabia, UAE, Kuwait, Rest of Middle East & Africa).

Endoscopic Hemostasis Devices Market

Competitive Analysis & Company Profiles:

This section of a Endoscopic Hemostasis Devices market report is a crucial segment that provides a comprehensive overview of the competitive landscape within the market. This section is vital for businesses, investors, and stakeholders seeking insights into key players, their market positioning, strengths, weaknesses, strategies, and potential impacts on the overall market dynamics. The chapter includes research methodology used to analyse the market competition, list of key players operating in the market, detailed company profile section which includes company overview, business verticals, financial performance, product/services benchmarking, geographical presence, and strategic initiatives.

Key Players Operating in the Endoscopic Hemostasis Devices Market are as follows:

• Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Cook Medical, Medtronic plc, ERBE Elektromedizin GmbH, Johnson & Johnson (Ethicon Endo-Surgery), Pentax Medical (HOYA Corporation), STERIS plc, Fujifilm Holdings Corporation, Taewoong Medical Co. Ltd., B. Braun Melsungen AG, Karl Storz SE & Co. KG, Medi-Globe GmbH, Cantel Medical Corporation.

Endoscopic Hemostasis Devices Market

Report Scope:

Quintile Reports has segmented the Endoscopic Hemostasis Devices market into the following segments:

Based on Product, the Endoscopic Hemostasis Devices market is segmented into:

• Thermal Devices
• Mechanical Devices
• Closure Devices
• Topical Hemostatic Agents
• Ligation Clips
• Ligation Bands
• Hemorrhoidal
• Esophageal
• Injection Needles
• Hemostatic Spray
• Thermal Probes
• Contact Probes
• Noncontact Probes
• Argon Plasma Coagulation (APC)
• Radiofrequency Ablation (RFA)

Based on Application, the Endoscopic Hemostasis Devices market is segmented into:

• Upper Gastrointestinal Bleeding
• Lower Gastrointestinal Bleeding
• Non-variceal Gastrointestinal Bleeding
• Others

Based on End-use, the Endoscopic Hemostasis Devices market is segmented into:

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Outpatient Facilities

Report Scope	Details
Report Version	2026
Growth Rate	CAGR of 4.32 from 2026 to 2035
Base year	2025
Actual estimates/Historical data	2017 - 2024
Forecast period	2026 - 2035
Quantitative units	Revenue in USD million/billion & CAGR from 2026 to 2035
Country scope	North America (U.S., Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Sweden, Denmark, Norway, Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, Thailand, Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, Colombia, Rest of Latin America), Middle East & Africa (South Africa, Saudi Arabia, UAE, Kuwait, Rest of Middle East & Africa).
The Segment covered by Product	Thermal Devices Mechanical Devices Closure Devices Topical Hemostatic Agents Ligation Clips Ligation Bands Hemorrhoidal Esophageal Injection Needles Hemostatic Spray Thermal Probes Contact Probes Noncontact Probes Argon Plasma Coagulation (APC) Radiofrequency Ablation (RFA)
The Segment covered by Application	Upper Gastrointestinal Bleeding Lower Gastrointestinal Bleeding Non-variceal Gastrointestinal Bleeding Others
Companies covered	Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Cook Medical, Medtronic plc, ERBE Elektromedizin GmbH, Johnson & Johnson (Ethicon Endo-Surgery), Pentax Medical (HOYA Corporation), STERIS plc, Fujifilm Holdings Corporation, Taewoong Medical Co. Ltd., B. Braun Melsungen AG, Karl Storz SE & Co. KG, Medi-Globe GmbH, Cantel Medical Corporation.
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Free customization scope (equivalent to 5 analyst working days)	If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of the customization

Key Reasons to Acquire the Endoscopic Hemostasis Devices Market Research Report:

• This report offers a comprehensive analysis of the Endoscopic Hemostasis Devices market from 2017 to 2035, including market segments, current trends, estimations, and dynamics
• It also provides information on key drivers, restraints, and opportunities
• Porter's five forces analysis is used to assess the potency of buyers and suppliers, helping stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network
• The report includes an in-depth analysis of the Endoscopic Hemostasis Devices market segmentation to identify prevailing market opportunities
• Major countries in each region are mapped according to their revenue contribution to the global market
• Market player positioning is also analyzed to facilitate benchmarking and provide a clear understanding of the present position of the market players
• The report includes an analysis of the regional and global Endoscopic Hemostasis Devices market trends, key players, market segments, application areas, and market growth strategies

Endoscopic Hemostasis Devices Market

Available Customizations:

With the given market data, Quintile Reports offers customizations according to the company's specific needs. The following customization options are available for the report:

• You may ask for a global, regional, or country-specific report.
• You may ask if there are any particular types, applications, or products on which you would like to focus.
• You may ask for specific competitors/players to be profiled.

Endoscopic Hemostasis Devices Market Report

Statistics for the 2025 Endoscopic Hemostasis Devices market share, size, and revenue growth rate were created by Quintile Report™. Endoscopic Hemostasis Devices analysis includes a market forecast outlook for 2035 and a historical overview. Get a free PDF sample of this market analysis, please get in touch with our principal analyst at sales@quintilereports.com